T cell therapies for lymphoma: Broadening applicability Event as iCalendar

20 August 2018

1 - 2pm

Venue: Mac 1, Biology Building

Location: 5 Symonds Street, Auckland Central

Host: SBS

Contact info: Rod Dunbar

Contact email: r.dunbar@auckland.ac.nz

Professor Catherine M Bollard
Professor Catherine M Bollard (MD, MBChB)

Speaker: Professor Catherine M Bollard (MD, MBChB), Director of the Center for Cancer and Immunology, Children’s Research Institute, Children’s National, Washington, DC, USA

In this seminar, Professor Bollard will focus on the recent advances in adoptive T-cell immunotherapies for lymphoma, not only for patients after hematopoietic stem cell transplantation, but also in the autologous setting using T cells early in the disease process for the treatment of the highest-risk patients with lymphomas.

The particular emphasis is to highlight the role of T-cell therapies for hematologic malignancies using a non-gene-transfer approach to direct specificity, including the clinical use of T-cell therapies for virus-associated lymphomas and strategies for targeting non-viral lymphoma-associated antigens.